Activists campaign for better access to ‘HIV morning-after pill’

As rates of HIV diagnoses rise among gay men, advocates campaign to raise awareness for preventative treatment after unsafe sex

Two years ago, James Krellenstein had unprotected sex. Luckily, the 22-year-old knew exactly what to do. The next day, he took a train from his parents’ house on Long Island to see a doctor at Bellevue Hospital in New York City. The doctor prescribed James PEP – a strong combination of drugs usually prescribed for people who already have HIV.

Months later, Krellenstein found out his partner from that night was indeed HIV-positive. But James remained negative. PEP’s little-known effectiveness in preventing the virus taking hold in someone’s body has led it to be dubbed the “morning-after pill for HIV”.

Yet Krellenstein’s experience remains rare. While the idea of treating people who may have been exposed to HIV with PEP has gained ground among doctors and activists over the last few years, most local governments in the United States have yet to implement a comprehensive PEP distribution or education program. That’s left many who are most at risk from contracting HIV unaware the option even exists.

Peter Moskowitz
The Guardian
Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below